Global Health Board of Directors
Get the latest insights into the leadership at Global Health. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Rahul Ranjan | Company Secretary & Compliance Officer |
| Naresh Trehan | Chairman & Managing Director |
| Sunil Sachdeva | Non Independent & Non Executive Director |
| Ravi Kant Jaipuria | Nominee Director |
| Praveen Mahajan | Non Executive Independent Director |
| Vikram Singh Mehta | Non Executive Independent Director |
| Hari Shanker Bhartia | Non Executive Independent Director |
| Rajan Bharti Mittal | Non Executive Independent Director |
| Ravi Gupta | Non Executive Independent Director |
| Pankaj Prakash Sahni | Whole Time Director & Chief Executive Officer |
| Shonan Purie Trehan | Non Executive Independent Director |
Global Health FAQs
The board at Global Health consists of experienced professionals, including Rahul Ranjan, Naresh Trehan, and others, overseeing the company’s strategic and corporate governance.
Directors at Global Health are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Rahul Ranjan is the current chairman at Global Health.
Executive directors at Global Health are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Global Health adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Global Health, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
